Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2001034094) NOVEL COMPOUNDS TO TREAT DIABETES AND ASSOCIATED CONDITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.: WO/2001/034094 International Application No.: PCT/US2000/030927
Publication Date: 17.05.2001 International Filing Date: 08.11.2000
Chapter 2 Demand Filed: 01.06.2001
IPC:
C07C 69/736 (2006.01)
C CHEMISTRY; METALLURGY
07
ORGANIC CHEMISTRY
C
ACYCLIC OR CARBOCYCLIC COMPOUNDS
69
Esters of carboxylic acids; Esters of carbonic or haloformic acids
66
Esters of carboxylic acids having esterified carboxyl groups bound to acyclic carbon atoms and having any of the groups OH, O-metal, -CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
73
of unsaturated acids
734
Ethers
736
the hydroxy group of the ester being etherified with a hydroxy compound having the hydroxy group bound to a carbon atom of a six-membered aromatic ring
Applicants:
NEOGI, Partha [US/US]; US (UsOnly)
NAG, Bishwajit [US/US]; US (UsOnly)
LAKNER, Frederick, J. [US/US]; US (UsOnly)
DEY, Debendranath [IN/US]; US (UsOnly)
MEDICHERLA, Satyanarayana [US/US]; US (UsOnly)
CALYX THERAPEUTICS, INC. [US/US]; 3525 Breakwater Avenue Hayward, CA 94545, US (AllExceptUS)
Inventors:
NEOGI, Partha; US
NAG, Bishwajit; US
LAKNER, Frederick, J.; US
DEY, Debendranath; US
MEDICHERLA, Satyanarayana; US
Agent:
KOKULIS, Paul, N.; Pillsbury Winthrop LLP 1100 New York Avenue, NW Washington, DC 20005, US
Priority Data:
09/436,04708.11.1999US
Title (EN) NOVEL COMPOUNDS TO TREAT DIABETES AND ASSOCIATED CONDITIONS
(FR) NOUVEAUX COMPOSES UTILES POUR TRAITER LE DIABETE ET LES PATHOLOGIES ASSOCIEES
Abstract:
(EN) Compounds are provided that lower blood glucose concentrations, lower serum triglyceride concentrations, lower systolic blood pressure, and increase glucose uptake by adipose tissue, but do not affect the expression of PPAR-$g(g) by adipose tissue.
(FR) On décrit des composés qui réduisent les concentrations de glucose dans le sang, réduisent les concentrations sériques de triglycérides, réduisent la tension artérielle systolique et augmentent le recaptage du glucose par le tissu adipeux, mais qui n'affectent pas l'expression de PPAR-$g(g) par le tissu adipeux.
front page image
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW
African Regional Intellectual Property Organization (ARIPO) (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (EPO) (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)